Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

60.0%

3 terminated/withdrawn out of 5 trials

Success Rate

40.0%

-46.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01122173Not ApplicableTerminated

Use of the Hansen Medical System in Patients With Paroxysmal Atrial Fibrillation

Role: lead

NCT00982475Not ApplicableCompleted

Alster Man and Machine: Comparison of Manual and Mechanical Remote Robotic Catheter Ablation for Drug-Refractory Atrial Fibrillation

Role: collaborator

NCT01984437Terminated

Registry of the Magellan Robotic System

Role: lead

NCT02369692Terminated

Embolization Procedures in the Peripheral Vasculature Using the Magellan™ Robotic System

Role: lead

NCT01182389Not ApplicableCompleted

A Study of Early Robotic Ablation by Substrate Elimination of Ventricular Tachycardia

Role: collaborator

All 5 trials loaded